Sven Arne Silfverdal

Senior lecturer/senior physician at Department of Clinical Sciences
Pediatrics

Publications

Author

Title

Year sorteringsordning

Fulltext

Hasslöf, Pamela
Karlsson Videhult, Frida
Silfverdal, Sven Arne; et al.

Vitamin D Insufficiency among Women Post-Partum in Northern Sweden: A Public Health Concern
Food and Nutrition Sciences

2017

Download

Vesikari, Timo
Silfverdal, Sven-Arne
Jordanov, Emilia; et al.

A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3-,5-and 11-to 12-month Schedule
The Pediatric Infectious Disease Journal, 36(1): 87-93

2017

-

Öhlund, Inger
Lind, Torbjörn
Hernell, Olle; et al.

Increased vitamin D intake differentiated according to skin color is needed to meet requirements in young Swedish children during winter: a double-blind randomized clinical trial
American Journal of Clinical Nutrition, 106(1): 105-112

2017

-

Silfverdal, Sven Arne
Coremans, Vanessa
Francois, Nancy; et al.

Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)
Expert Review of Vaccines, 16(2): 109-121

2017

-

Prymula, Roman
Szenborn, Leszek
Silfverdal, Sven-Arne; et al.

Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: results from a randomized phase II study in infants
Vaccine, 35(35B): 4603-4611

2017

-

Vetter, Volker
Baxter, Roger
Denizer, Gülhan; et al.

Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.
Expert Review of Vaccines, 15(5): 641-658

2016

-

Karlsland Åkeson, Pia
Lind, Torbjörn
Hernell, Olle; et al.

Serum Vitamin D Depends Less on Latitude Than on Skin Color and Dietary Intake During Early Winter in Northern Europe
Journal of Pediatric Gastroenterology and Nutrition - JPGN, 62(4): 643-649

2016

-

Silfverdal, Sven-Arne
Icardi, Giancarlo
Vesikari, Timo; et al.

A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months
Vaccine, 34(33): 3810-3816

2016

-

Vesikari, Timo
Richardus, Jan Hendrik
Berglund, Johan; et al.

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine Two Open-label, Randomized Trials
The Pediatric Infectious Disease Journal, 34(7): 774-782

2015

-

Holl, Katsiaryna
Rosenlund, Mats
Giaquinto, Carlo; et al.

The Impact of Childhood Acute Otitis Media on Parental Quality of Life in a Prospective Observational Cohort Study
Clinical drug investigation, 35(10): 613-624

2015

Download